Navigation Links
Medtronic ITREL 3 Model 7425G Neurostimulator (Enterra™ Therapy)

ProductsMedtronic ITREL 3 Model 7425G Neurostimulator (Enterra™ Therapy)
Company Medtronic Gastroenterology
Item Medtronic ITREL 3 Model 7425G Neurostimulator (Enterra™ Therapy)
Features 
  • Implantable device
  • Battery powered
  • Commercially available in the U.S.
Description The ITREL 3 is a battery powered implantable device that is commercially available in the U.S.

Enterra™ Therapy is indicated for the treatment of chronic nausea and vomiting associated with gastroparesis when conventional drug therapies are not providing adequate relief of symptons for diabetic or idiopathic patients.

Gastroparesis is a stomach disorder in which food moves through the stomach more slowly than normal. In some patients, this condition results in severe, chronic nausea and vomiting that cannot be adequately controlled by available drugs. These patients have difficulty maintaining their nutricial needs, and may require some form of tube feeding to ensure adequate nutrition.

Enterra Therapy uses mild electrical pulses to stimulate the stomach. This electrical stimulation may reduce the symptoms associated with gastroparesis including nausea and vomiting.
Info Medtronic Gastroenterology
Customer Service: (763) 514-4000

Related medicine products :

1. Medtronic Aortic Punches
2. Cables for Pre-sterilized Medtronic electrodes
3. Medtronic Precision Plus System
4. Medtronic Hall™ Mechanical Heart Valve
5. Medtronic Resting Heart™ System
6. Medtronic Model 4351 Lead (Enterra™ Therapy)
7. Reliance Stool, Model 5346
8. Reliance Stools, Model 5340
9. Reliance Stool, Model 5356
10. Reliance Stool, Model 5348
11. Pachymetric Analyzer Model 55
Total IgE Control...
The K-ASSAY Lipid Controls are assayed controls produced from fresh human sera to monitor the accuracy and precision of quantitative lipid determinations of human sera specimens....
The K-ASSAY hs-CRP Control Set is intended to be used as a consistent test sample of known concentrations for monitoring the performance of hs-CRP (high sensitive C-Reactive Protein) immunoturbimetri...
... K-ASSAY ASO / RF / ... to be used as a ... concentration for monitoring the performance ... Rheumatoid Factor (RF), and C-Reactive ...
Medicine Products:
(Date:3/23/2017)... ... March 23, 2017 , ... PAINWeekEnd (PWE) Oklahoma City, on ... Avenue, will be an educational and exciting program providing busy clinicians and allied ... chronic pain. , Oklahoma is in a healthcare crisis. The state ranks 46th ...
(Date:3/23/2017)... ... 2017 , ... 82% of adults are unaware of the dangers that infectious bacteria play in ... minimum two times a day that dentists recommend. The ramifications of improper oral upkeep go ... and adults missing 164 million hours of work each year due to dental issues. That ...
(Date:3/23/2017)... ... March 23, 2017 , ... Benefits ... an innovative mobile app and centralized benefits dashboard solving one of the top ... from multiple locations. For the first time, employees can access up-to-date information and ...
(Date:3/23/2017)... ... March 23, 2017 , ... The Wound ... by HMP Communications Holdings, LLC, today announced that RestorixHealth® has officially ... of wound centers interested in becoming Certified Wound Specialist Physicians (CWSP®). , ...
(Date:3/23/2017)... ... March 23, 2017 , ... March 23, 2017 ... organizations to easily reprint customer invoices, bills, statements and other correspondence when they ... steps needed to retrieve and print the documents and batch them for efficient ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... New York , March 23, 2017 /PRNewswire/ ... market exhibits a consolidated vendor landscape with the top ... overall market in 2015. These companies are Stryker ... Inc., Hygia Health Services, Inc., and VANGUARD AG. ... reprocessed medical devices market is witnessing the prevalence ...
(Date:3/23/2017)... March 23, 2017 Piramal ... Limited, anuncia el nombramiento de Stuart E. ... plataforma de servicios integrados completa para su base ... cargo clave en el crecimiento y ejecución de ... responsable de impulsar todas las actividades de desarrollo ...
(Date:3/23/2017)... Israel , March 23, 2017 ... oncology and immunology, announced today that it has acquired Agalimmune ... platform. Acquisition consideration consisted of a $6 million upfront payment, ... in BioLineRx shares. Additional future payments may be made based ... ...
Breaking Medicine Technology: